A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a highly fatal lung disease of unknown etiology with a median survival after diagnosis of only 2–3 years. Its poor prognosis is due to the limited therapy options available as well as the lack of effective prognostic indicators. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Lingxiao, Gong, Gencheng, Wu, Wenjuan, Li, Nana, Li, Zhaonan, Chen, Shanshan, Li, Ping, Chen, Tengfei, Zhao, Huasi, Hu, Chunling, Fang, Zeming, Wang, Yan, Liu, Hongping, Cui, Panpan, Zhang, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576669/
https://www.ncbi.nlm.nih.gov/pubmed/34790776
http://dx.doi.org/10.21037/atm-21-4545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576669/
https://www.ncbi.nlm.nih.gov/pubmed/34790776
http://dx.doi.org/10.21037/atm-21-4545

Ejemplares similares